Kymera Therapeutics, Inc. (KYMR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Question-and-Answer SessionBruce JacobsChief Financial Officer Sure. Ellie, so first of all, thanks for having us. I think this is the OG Miami March Conference. So we're happy to be ending our week here. So thank you. Yes. So it's a good time to ask that question. Kymera is actually coming up next month on our 10-year anniversary of the company's founding. From the beginning, the company was founded to really capitalize on this exciting new modality, targeted protein degradation. And we approached it in a ...